{"url_path":"/register/2026-09-14/2026-18646","section_key":"summary","section_title":"Draft NIH Biosafety Policy for Research Involving Biohazards","topic":"register","document":{"doc_type":"Notice","doc_date":"2026-09-14","source_url":"https://www.federalregister.gov/documents/2026/09/14/2026-18646/draft-nih-biosafety-policy-for-research-involving-biohazards","accession_number":null,"cik":null,"ticker":null,"issuer_name":null,"edgar_url":null,"primary_entity_key":null,"primary_entity_name":"Health and Human Services Department"},"word_count":110,"has_tables":false,"body_markdown":"# Draft NIH Biosafety Policy for Research Involving Biohazards\n\n**Type:** Notice\n**Published:** 2026-09-14\n**Citation:** 91 FR 58132\n**Agencies:** Health and Human Services Department, National Institutes of Health\n**Source:** https://www.federalregister.gov/documents/2026/09/14/2026-18646/draft-nih-biosafety-policy-for-research-involving-biohazards\n\n## Abstract\nAs the world's largest public funder of biomedical research, the National Institutes of Health (NIH) is committed to ensuring that gold-standard science is conducted under gold-standard biosafety conditions. To achieve this goal, NIH is proposing a new policy that modernizes and strengthens biosafety practices to ensure that oversight keeps pace with evolving risks. NIH is requesting public input on a new, comprehensive biosafety policy proposal that, when finalized, will replace the current NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (https://osp.od.nih.gov/wp-content/ uploads/NIH_Guidelines.pdf)."}